Cited by 80Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementReproductive Health and Contraception

Desogestrel‐only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open‐label comparative study

Open access
Leone Roberti Maggiore, Umberto, Remorgida, Valentino, Scala, Carolina, Tafi, Emanuela, Venturini, Pier L., Ferrero, Simone·2014·Acta Obstetricia et Gynecologica Scandinavica

Abstract

Objective: To compare the efficacy of two hormonal therapies in treating symptoms caused by bowel endometriosis. Design: Patient preference study. Setting: University hospital. Population: A total of 143 women with rectovaginal endometriosis infiltrating the rectum. Methods: This study was performed between January 2008 and June 2011. Patients were treated with a desogestrel‐only contraceptive pill or with the sequential combined contraceptive vaginal ring for 12 months. Main outcome measures: The primary endpoint of the study was the rate of satisfied patients at 12‐month follow up. The changes in symptoms and in the volume of the nodules were secondary endpoints. Results: At 12‐month follow up, the rate of satisfied patients was higher in the group treated with the desogestrel‐only contraceptive pill than in the group treated with the sequential combined contraceptive vaginal ring (p = 0.004). When only changes in gastrointestinal symptoms were considered, 50% of patients treated with the desogestrel‐only contraceptive pill and 31.3% of those treated with the sequential combined contraceptive vaginal ring were satisfied (p = 0.037). The reduction in the volume of the nodules, the percentages of patients who discontinued the therapy after the completion of the study and of those who decided to undergo surgery were similar between the two groups. Conclusions: Both hormonal therapies are efficacious in treating symptoms caused by rectovaginal endometriosis infiltrating the rectum. Patient satisfaction is higher with the desogestrel‐only pill than with a vaginal ring.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/aogs.12326

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • At 12-month follow-up, the rate of satisfied patients was higher with desogestrel-only pill compared to sequential estro-progestin pill.

    “At 12‐month follow up, the rate of satisfied patients was higher in those treated with the desogestrel‐only pill compared to those on sequential estro-progestin pill [229].”

    From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [229]

    The Results report higher satisfaction at 12 months with desogestrel (61.7%) than with the sequential treatment (36.1%; p = 0.004). However, the Methods and Conclusion identify the comparator as a sequential combined contraceptive vaginal ring, not an estro-progestin pill. (LLM, conf=0.93)

    Experimental — accuracy not yet measured
  • DSG treatment in women with symptomatic rectovaginal endometriosis reduces lesion volume and improves gastrointestinal symptoms, chronic pelvic pain, and deep dyspareunia.

    “DSG treatment of women with symptomatic rectovaginal endometriosis induced volume size reduction and improvement of gastrointestinal symptoms, chronic pelvic pain, and deep dyspareunia.”
  • In a patient preference trial of symptomatic rectovaginal endometriosis, satisfaction rate was higher with DSG-POP than vaginal ring (61.7% vs 36.1%), and gastrointestinal symptoms, chronic pelvic pain and deep dyspareunia improved more in DSG-POP group.

    “At the end of the study, the rate of satisfied women was higher in the group treated with DSG-POP (61.7% vs. 36.1%).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Leone Roberti Maggiore, U., Remorgida, V., Scala, C., Tafi, E., Venturini, P. L., & Ferrero, S.
Affiliations
  • Department of Obstetrics and Gynecology San Martino Hospital and National Institute for Cancer Research University of Genoa Genoa Italy
  • Ospedale Policlinico San Martino (IT)
Venue
Acta Obstetricia et Gynecologica Scandinavica
Publisher
Wiley
Published
2014-02-19
Volume
93
Issue
3
Pages
239-247
ISSN
  • 0001-6349 (ISSN-L)
  • 1600-0412
OpenAlex
W2152955646
Cited by
80
References
31
Citations by year
2026: 4 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 2 · 2020: 11 · 2019: 4 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 6 · 2014: 3
FWCI
7.65
Type
journal article
Language
en
Open access
Locations
  • Acta Obstetricia Et Gynecologica Scandinavica (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
rectovaginal endometriosis, bowel endometriosis, contraceptive vaginal ring, patient satisfaction, gastrointestinal symptoms, nodule volume
MeSH terms
Adult, Contraceptive Devices, Female, Contraceptives, Oral, Synthetic, Drug Combinations, Endometriosis, Ethinyl Estradiol, Female, Follow-Up Studies, Humans, Prospective Studies, Rectal Diseases, Patient Satisfaction, Desogestrel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review